MetaADEDB 2.0 @ LMMD
GS-7340
(LDEKQSIMHVQZJK-CAQYMETFSA-N)
Structure
SMILES
C[C@H](Cn1cnc2c1ncnc2N)OC[P@@](=O)(N[C@H](C(=O)OC(C)C)C)Oc1ccccc1
Type(s)
Approved
ATC code(s)
J05AF13; J05AR17; J05AR18; J05AR19; J05AR20; J05AR22
Molecular Formula:
C21H29N6O5P
Molecular Weight:
476.466
Log P:
3.9450
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
2
TPSA:
153.29
CAS Number(s):
379270-37-8; 383365-04-6
Synonym(s)
1.
GS-7340
2.
tenofovir alafenamide
3.
vemlidy
External Link(s)
MeSHC442442
PubChem Compound9574768
ChEBI90926
CHEMBLCHEMBL2107825
DrugBankDB09299
DrugCentral4944
KEGGdr:D10428
ZINC100055899
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 22US FAERS
2HeadacheFAERS: 18US FAERS
3ArthralgiaFAERS: 16US FAERS
4Intentional dose omissionFAERS: 16US FAERS
5Product dose omissionFAERS: 16US FAERS
6NauseaFAERS: 13US FAERS
7Back PainFAERS: 11US FAERS
8DizzinessFAERS: 10US FAERS
9PruritusFAERS: 10US FAERS
10Abdominal PainFAERS: 8US FAERS
11Drug dose omissionFAERS: 8US FAERS
12Maternal exposure during pregnancyFAERS: 6US FAERS
13Alanine Aminotransferase IncreasedFAERS: 5US FAERS
14AstheniaFAERS: 5US FAERS
15Chest discomfortFAERS: 5US FAERS
16Drug ineffectiveFAERS: 5US FAERS
17Intentional product use issueFAERS: 5US FAERS
18PainFAERS: 5US FAERS
19Product storage errorFAERS: 5US FAERS
20Therapy cessationFAERS: 5US FAERS
21Viral load increasedFAERS: 5US FAERS
22Abdominal discomfortFAERS: 4US FAERS
23Bone painFAERS: 4US FAERS
24MyalgiaFAERS: 4US FAERS
25Product dispensing errorFAERS: 4US FAERS
26ArthropathyFAERS: 3US FAERS
27Blood creatinine increasedFAERS: 3US FAERS
28Cerebral InfarctionFAERS: 3US FAERS
29Cerebrovascular accidentFAERS: 3US FAERS
30ChromaturiaFAERS: 3US FAERS
31DysgeusiaFAERS: 3US FAERS
32FlushingFAERS: 3US FAERS
33Hepatitis B DNA increasedFAERS: 3US FAERS
34HypersensitivityFAERS: 3US FAERS
35MalaiseFAERS: 3US FAERS
36Memory impairmentFAERS: 3US FAERS
37No adverse eventFAERS: 3US FAERS
38Product use complaintFAERS: 3US FAERS
39Product use issueFAERS: 3US FAERS
40SomnolenceFAERS: 3US FAERS
41VomitingFAERS: 3US FAERS
42Wrong technique in product usage processFAERS: 3US FAERS
43Acute kidney injuryFAERS: 2US FAERS
44AlopeciaFAERS: 2US FAERS
45Blood cholesterol increasedFAERS: 2US FAERS
46Blood phosphorus decreasedFAERS: 2US FAERS
47ChemotherapyFAERS: 2US FAERS
48ChillsFAERS: 2US FAERS
49Completed SuicideFAERS: 2US FAERS
50Counterfeit product administeredFAERS: 2US FAERS
51Depressed moodFAERS: 2US FAERS
52Dry skinFAERS: 2US FAERS
53Emergency CareFAERS: 2US FAERS
54Exposure via body fluidFAERS: 2US FAERS
55Extra dose administeredFAERS: 2US FAERS
56Hepatitis B DNA assay positiveFAERS: 2US FAERS
57Inability to afford medicationFAERS: 2US FAERS
58InfectionFAERS: 2US FAERS
59Intentional product misuseFAERS: 2US FAERS
60Maternal exposure timing unspecifiedFAERS: 2US FAERS
61Musculoskeletal PainFAERS: 2US FAERS
62Myocardial InfarctionFAERS: 2US FAERS
63NasopharyngitisFAERS: 2US FAERS
64Peripheral swellingFAERS: 2US FAERS
65PneumoniaFAERS: 2US FAERS
66Product counterfeitFAERS: 2US FAERS
67Rheumatoid ArthritisFAERS: 2US FAERS
68Transaminases increasedFAERS: 2US FAERS
69TremorFAERS: 2US FAERS
70Unevaluable eventFAERS: 2US FAERS
71Urinary tract infectionFAERS: 2US FAERS
72AcneFAERS: 1US FAERS
73Ammonia increasedFAERS: 1US FAERS
74AmnesiaFAERS: 1US FAERS
75Ankle FractureFAERS: 1US FAERS
76ApathyFAERS: 1US FAERS
77Arterial graftFAERS: 1US FAERS
78ArthritisFAERS: 1US FAERS
79AsthmaFAERS: 1US FAERS
80Blood cholesterol abnormalFAERS: 1US FAERS
81Blood cholesterolFAERS: 1US FAERS
82Blood creatine phosphokinase increasedFAERS: 1US FAERS
83Blood potassium increasedFAERS: 1US FAERS
84Blood pressure fluctuationFAERS: 1US FAERS
85Blood triglycerides increasedFAERS: 1US FAERS
86Bone density decreasedFAERS: 1US FAERS
87Bowel movement irregularityFAERS: 1US FAERS
88Brain ContusionFAERS: 1US FAERS
89Burning sensationFAERS: 1US FAERS
90Compression fractureFAERS: 1US FAERS
91ConstipationFAERS: 1US FAERS
92Depressed Level of ConsciousnessFAERS: 1US FAERS
93Diabetes MellitusFAERS: 1US FAERS
94Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
95Drug dispensing errorFAERS: 1US FAERS
96Drug resistanceFAERS: 1US FAERS
97DysuriaFAERS: 1US FAERS
98Endodontic procedureFAERS: 1US FAERS
99EpistaxisFAERS: 1US FAERS
100Erectile dysfunctionFAERS: 1US FAERS
101ErythemaFAERS: 1US FAERS
102Evans syndromeFAERS: 1US FAERS
103Feeling abnormalFAERS: 1US FAERS
104Feeling jitteryFAERS: 1US FAERS
105FlatulenceFAERS: 1US FAERS
106Foaming at mouthFAERS: 1US FAERS
107Gastrointestinal obstructionFAERS: 1US FAERS
108General physical condition decreasedFAERS: 1US FAERS
109General physical health deteriorationFAERS: 1US FAERS
110Hepatic cancer metastaticFAERS: 1US FAERS
111Hepatic cancer stage IIIFAERS: 1US FAERS
112Hepatitis B e antigen positiveFAERS: 1US FAERS
113Hepatitis BFAERS: 1US FAERS
114Hepatitis CFAERS: 1US FAERS
115HepatitisFAERS: 1US FAERS
116Hepatorenal SyndromeFAERS: 1US FAERS
117HypophagiaFAERS: 1US FAERS
118Incorrect route of drug administrationFAERS: 1US FAERS
119InfluenzaFAERS: 1US FAERS
120Joint swellingFAERS: 1US FAERS
121LazinessFAERS: 1US FAERS
122Limb discomfortFAERS: 1US FAERS
123Low density lipoprotein abnormalFAERS: 1US FAERS
124LymphomaFAERS: 1US FAERS
125MarasmusFAERS: 1US FAERS
126MastectomyFAERS: 1US FAERS
127Muscle tightnessFAERS: 1US FAERS
128Musculoskeletal stiffnessFAERS: 1US FAERS
129Oral painFAERS: 1US FAERS
130PalpitationsFAERS: 1US FAERS
131Pancreatic carcinomaFAERS: 1US FAERS
132PancreatitisFAERS: 1US FAERS
133Paternal exposure before pregnancyFAERS: 1US FAERS
134Peritonsillar AbscessFAERS: 1US FAERS
135PoisoningFAERS: 1US FAERS
136Premature MenopauseFAERS: 1US FAERS
137Prescribed underdoseFAERS: 1US FAERS
138Product container issueFAERS: 1US FAERS
139Product container seal issueFAERS: 1US FAERS
140Product physical issueFAERS: 1US FAERS
141Pulmonary EmbolismFAERS: 1US FAERS
142Quality of life decreasedFAERS: 1US FAERS
143Renal painFAERS: 1US FAERS
144RhabdomyolysisFAERS: 1US FAERS
145Sexual DysfunctionFAERS: 1US FAERS
146Shunt occlusionFAERS: 1US FAERS
147SneezingFAERS: 1US FAERS
148StomatitisFAERS: 1US FAERS
149Suspected counterfeit productFAERS: 1US FAERS
150SyncopeFAERS: 1US FAERS
151Therapeutic product effect decreasedFAERS: 1US FAERS
152Therapy changeFAERS: 1US FAERS
153Thoracic vertebral fractureFAERS: 1US FAERS
154ThrombosisFAERS: 1US FAERS
155Tooth ResorptionFAERS: 1US FAERS
156Upper-airway cough syndromeFAERS: 1US FAERS
157UrticariaFAERS: 1US FAERS
158Weight decreasedFAERS: 1US FAERS
159Wrong product administeredFAERS: 1US FAERS
160jaundiceFAERS: 1US FAERS
161treatment failureFAERS: 1US FAERS
162Product substitution issueCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.